Navigation Links
First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval
Date:7/22/2008

ditional funding to support its business activities; Rosetta's dependence on third parties for development, manufacture, marketing, sales, and distribution of products; Rosetta's ability to successfully develop its candidate tools, products and services, all of which are in early stages of development; Rosetta's ability to obtain regulatory clearances or approvals that may be required for its products and services; the ability to obtain coverage and adequate payment from health insurers for the products and services comprising Rosetta's technology; competition from others using technology similar to Rosetta's and others developing products for similar uses; Rosetta's dependence on collaborators; and Rosetta's short operating history; as well as those risks more fully discussed in the "Risk Factors" section of Rosetta's Annual Report on Form 20-F for the year ended December 31, 2007 as filed with the Securities and Exchange Commission. In addition, any forward-looking statements represent Rosetta's views only as of the date of this release and should not be relied upon as representing its views as of any subsequent date. Rosetta does not assume any obligation to update any forward-looking statements unless required by law.

(1) Avastin(TM), a registered trademark of Genentech, Inc.

(2) Field RW, Smith BJ, Platz CE, Robinson RA, Neuberger JS, Brus CP, et al. Lung cancer histologic type in the Surveillance, epidemiology, and end results registry versus independent review. J Natl Cancer Inst 2004;96:1105--7

(3) Andreas Stang ,Hermann Pohlabeln , Klaus M.Muller ,Ingeborg Jahn , Klaus Giersiepen, Karl-Heinz Jockel Diagnostic agreement in the histopathological evaluation of lung cancer tissue in a population-based case-control study. Lung Cancer (2006) 52 ,29 --36

Contact:

Media& Investors

Ron Kamienchick

T: +1-646- 509 1893

E: investors@rosettagenomics.com


'/>"/>
SOURCE Rosetta Genomics Ltd
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Ekkyo Describes the First Benefits of Controlled Hyperthermia in Humans in "Lasers in Surgery and Medicine"
2. Wacker Validates Scalability of Anticalin(R) Production With E.coli Secretion Technology and Will Produce Pieris First Clinical Candidate PRS-050
3. Bapineuzumab To Become the First-to-Market Disease-Modifying Alzheimers Drug After Flurizans Discontinuation
4. Insmed Announces First Human Bioequivalence Data for a Follow-on Biologic by a U.S. Company
5. Sonablate(R) International HIFU Registry is the First Worldwide HIFU Clinical Registry for Prostate Cancer Treatments
6. Patient Receives vProtect(TM) Luminal Shield in First-Ever Vulnerable Plaque Clinical Trial
7. Peregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer
8. First Breast Cancer Patient Receives Treatment in National Electronic Brachytherapy Registry Launched by Three Physician Societies
9. Olanzapine Long-Acting Injection (LAI) Data Presented at First Annual Schizophrenia International Research Society Conference
10. Accumetrics Announces the Launch and First Patient Enrolled Into the GRAVITAS Trial
11. Fox Chase Cancer Center and VisEn Medical Announce Program to Advance First Clinical Trials of Novel Fluorescence Molecular Imaging Technologies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... , August 27, 2015 According to ... (Transfer, Hammock, Toilet, Seating, Universal, Standing, Bariatric ), Material (Nylon, Padded, ... Forecast to 2020", published by MarketsandMarkets, the Medical Lifting Sling Market ... 411.5 Million in 2015, at a CAGR of 11.4 % from ... ma rket data T ables and ...
(Date:8/27/2015)... Ga. , Aug. 27, 2015  MiMedx Group, ... medicine company utilizing human amniotic tissue and patent-protected ... therapies for the Wound Care, Surgical, Orthopedic, Spine, ... responded today and corrected the multiple inaccuracies in ... Foundation ("MTF") regarding the recent rulings from the ...
(Date:8/27/2015)... August 27, 2015 According to ... by Type (Integrated, Standalone), by Deployment Mode (Web based, ... Emergency Healthcare Service Providers), by Component - Global Trends ... Market is estimated at $501.1 Million 2014, and is ... CAGR of 7.6% from 2014 to 2019. ...
Breaking Medicine Technology:Medical Lifting Sling Market Worth USD 706.0 Million by 2020 2Medical Lifting Sling Market Worth USD 706.0 Million by 2020 3Medical Lifting Sling Market Worth USD 706.0 Million by 2020 4MiMedx Corrects Inaccuracies In MTF Press Release Regarding The Recent Rulings From The Patent Trial And Appeal Board 2MiMedx Corrects Inaccuracies In MTF Press Release Regarding The Recent Rulings From The Patent Trial And Appeal Board 3MiMedx Corrects Inaccuracies In MTF Press Release Regarding The Recent Rulings From The Patent Trial And Appeal Board 4Radiology Information Systems Market Worth $722.7 Million by 2019 2Radiology Information Systems Market Worth $722.7 Million by 2019 3Radiology Information Systems Market Worth $722.7 Million by 2019 4
... PRXL ) announced today it will be presenting ... von Rickenbach, Chairman and Chief Executive Officer will be making ... January 13, 2011. A live webcast of this ... of PAREXEL,s website at www.PAREXEL.com in the Upcoming ...
... Pharmaceuticals, Inc. (Nasdaq: AMLN ) will be presenting ... Francisco on Monday, January 10, 2011 at 4:30 p.m. ET ... and chief executive officer of Amylin Pharmaceuticals, will provide a ... be webcast through the "Investors" section of Amylin,s corporate website ...
Cached Medicine Technology:PAREXEL International to Present at J.P. Morgan Healthcare Conference 2
(Date:8/27/2015)... (PRWEB) , ... August 27, ... ... Black Swan Analysis signed a partnership agreement for quality market research promotion ... reports elaborated by Black Swan Analysis. , Commenting on the partnership agreement, ...
(Date:8/27/2015)... (PRWEB) , ... August 27, 2015 , ... Susan ... edge procedure to relieve vaginal discomfort due to pre- and post-menopause, chemotherapy, and child ... a CO2 laser, which delivers controlled energy to the vaginal tissue, revitalizing cells so ...
(Date:8/27/2015)... (PRWEB) , ... August 27, 2015 , ... Sunbelt® Bakery, ... high fructose corn syrup, is changing the expectation of how protein bars should taste ... indulgent taste unlike any other protein bar on the market today. , The ...
(Date:8/27/2015)... CT (PRWEB) , ... August 27, 2015 , ... ... List. , “The companies selected have the platforms required not only to effectively deliver, ... Ken Taylor, President of Training Industry, Inc. , For six consecutive years, NetDimensions ...
(Date:8/27/2015)... ... 27, 2015 , ... Healthpointe clinics are now offering Executive ... Orange County. , Designed to accommodate the busy lifestyles and work schedules ... its locations. Executive Physicals are scheduled so that busy professionals wait very ...
Breaking Medicine News(10 mins):Health News:Market Publishers Ltd and Black Swan Analysis Sign Partnership Agreement 2Health News:Market Publishers Ltd and Black Swan Analysis Sign Partnership Agreement 3Health News:LifeStream Health Centre & MedSpa Announces New Treatment for Vaginal Discomfort 2Health News:LifeStream Health Centre & MedSpa Announces New Treatment for Vaginal Discomfort 3Health News:Sunbelt® Bakery Changes the Expectations of How Protein Bars Should Taste with the Introduction of Its New Protein Delights 2Health News:Sunbelt® Bakery Changes the Expectations of How Protein Bars Should Taste with the Introduction of Its New Protein Delights 3Health News:NetDimensions Named Among Top 20 Learning Portal Companies of 2015 2Health News:NetDimensions Named Among Top 20 Learning Portal Companies of 2015 3Health News:Healthpointe Now Offering Executive Physicals 2
... As controversy swirls about proper clinical use of opioids and ... Society annual meeting shows that, contrary to widespread beliefs, less ... abuse who are prescribed opioids for chronic pain will show ... , In his plenary session address, Srinivasa Raja, MD, ...
... $20,000 Nationwide Scholarship, Competition with Celebrity Spokesperson Megyn Price of the ... ... YORK, May 9 The Tea Council of the USA,Inc. announced ... competition awarding one creative student $20,000,towards their education, in an effort ...
... Emilio and Gloria Estefan at the event to ... benefit ... Valeria Gastaldi, MIAMI, May 9 St. Jude Children,s Research Hospital(R),the ... Jude Angels & Stars Gala on Saturday,May 17, at the Adrienne Arsht ...
... Oceana, an international,ocean conservation group based in Washington, D.C., ... Consuming big fish high on,the food chain is the ... heavy,metal that can cause neurological and other health problems., ... Amber Valletta,offers a few tips for keeping your family ...
... JOSE, Calif., May 9 VNUS(R) Medical,Technologies, Inc. today ... to allow a second continuation patent application related to,the ... of,endovenous laser products. This comes on the heels of ... separate patent application, also filed,as a continuation of one ...
... the lives of 30% of infected patients in U.K., ... British research into Steno, one the most recent ... an incredible ability to resist antibiotics and other drugs, ... Stenotrophomonas maltophilia , thrives in moist environments, such ...
Cached Medicine News:Health News:Risks for painkiller abuse do not outweigh benefits in chronic pain 2Health News:Drink Tea. Win $20,000. Experience the 'Calm-A-Sutra of Tea' 2Health News:Drink Tea. Win $20,000. Experience the 'Calm-A-Sutra of Tea' 3Health News:Miami Rolls Out the Red Carpet for Latin Star Studded FedEx/St. Jude Gala 2Health News:Miami Rolls Out the Red Carpet for Latin Star Studded FedEx/St. Jude Gala 3Health News:Amber Valletta on Preventing Mercury Exposure 2Health News:Amber Valletta on Preventing Mercury Exposure 3Health News:U.S. Patent Office Allows Another Significant VNUS Patent 2Health News:U.S. Patent Office Allows Another Significant VNUS Patent 3Health News:Steno 'Superbug' Genome Shows Extreme Drug Resistance 2
The balloon catheter is designed to pass over a previously placed .015 inch diameter wire guide included. Supplied sterile in peel-open packages. Intended for one-time use....
Radiopaque markers are placed at the proximal and distal ends of the balloon. A special pin vise handle is included to stabilize the wire guide during introduction. Supplied sterile in peel-open pack...
Radiopaque markers are placed at the proximal and distal ends of the balloon. A special pin vise handle is included to stabilize the wire guide during introduction. Supplied sterile in peel-open pack...
... Technologies, The UroMax Ultra ia designed ... high pressure and low profile., Refolding ... a remarkably strong material that is ... materials., Non-Compliant Balloons, A compliant balloon ...
Medicine Products: